TRANSPLANT RECIPIENT (KIDNEY)
Clinical trials for TRANSPLANT RECIPIENT (KIDNEY) explained in plain language.
Never miss a new study
Get alerted when new TRANSPLANT RECIPIENT (KIDNEY) trials appear
Sign up with your email to follow new studies for TRANSPLANT RECIPIENT (KIDNEY), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene test before kidney transplant could prevent rejection and save money
Disease control Recruiting nowThis study tests whether doing a genetic test before a kidney transplant can help doctors choose the best starting dose of tacrolimus, an anti-rejection drug. About 114 adults waiting for a kidney transplant will be randomly assigned to either standard care or the genetic-testing…
Matched conditions: TRANSPLANT RECIPIENT (KIDNEY)
Phase: PHASE4 • Sponsor: Instituto de Investigación Hospital Universitario La Paz • Aim: Disease control
Last updated May 26, 2026 07:16 UTC
-
New hope for kidney transplant patients: a possible path to drug-free tolerance
Disease control Recruiting nowThis early-phase study tests a treatment called Sip-Tego in 12 adults with kidney failure who need a living-donor kidney transplant. The goal is to see if the treatment can train the body to accept the new kidney without needing lifelong anti-rejection drugs. Participants will be…
Matched conditions: TRANSPLANT RECIPIENT (KIDNEY)
Phase: EARLY_PHASE1 • Sponsor: Tatsuo Kawai, MD, PhD • Aim: Disease control
Last updated May 19, 2026 12:01 UTC